Laboratorios Andromaco

What Laboratorios Andromaco does

Laboratorios Andrómaco S.A. is a privately held Chilean pharmaceutical laboratory founded in 1942 that manufactures and distributes a portfolio of quality medications, bioequivalent generics, and consumer health products. The company's therapeutic portfolio spans central nervous system medications, vitamins, minerals, and supplements — the latter marketed through the D'Vida and ElcalFlex sub-brands. Approximately 60% of its production capacity is dedicated to bioequivalent and generic medications, and all production plants operate under GMP (Good Manufacturing Practice) certification with international quality standards compliance. The company positions itself as a key supplier to Cenabast, Chile's centralized public-sector pharmaceutical procurement agency, while also exporting to other Latin American countries, leveraging its GMP certification as the enabler for cross-border distribution. Its core customer base is Chilean patients and the public healthcare system, with the stated mission of expanding access to affordable, quality pharmaceutical products. Beyond the 2008 acquisition of Diagnotec, no subsequent M&A, funding rounds, or significant leadership transitions are disclosed. The business is privately held, with no parent company, institutional investors, or public market listing identified in the available source material, and detailed financial metrics including revenue and headcount are not disclosed.

Name

Laboratorios Andromaco

Legal name

Laboratorios Andrómaco

Website

https://laboratoriosandromaco.cl

Company type

Private

Founded year

1942

Operating status

Operating

Short description

Laboratorios Andrómaco is a privately held Chilean pharmaceutical laboratory, founded in 1942, that manufactures GMP-certified bioequivalent and generic medications, supplements, and CNS drugs, supplying primarily through the Chilean government procurement channel Cenabast and exporting across Latin America.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic pharmaceuticals
• Bioequivalent medications
• Pharmaceutical manufacturing
• Central nervous system drugs
• Vitamins and supplements

Headquarters

HQ city

Santiago De Calatrava

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from the sale of quality medications, bioequivalent drugs, and generic pharmaceuticals through government procurement (Cenabast) and regional exports

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Laboratorios Andrómaco is a Chilean pharmaceutical laboratory that manufactures and markets quality medications, with approximately 60% of its production dedicated to bioequivalent and generic drugs. Its portfolio covers Central Nervous System therapeutics plus vitamins, minerals, and supplements sold under the D'Vida and ElcalFlex sub-brands, all produced in GMP-certified facilities supplying both the Chilean public healthcare system via Cenabast and regional export markets.

Product overview

Laboratorios Andrómaco operates as a pharmaceutical laboratory producing a unified portfolio of quality medications centered around bioequivalent and generic drugs. The company offers products across multiple therapeutic areas including Central Nervous System medications, and vitamin/mineral supplements through sub-brands D'Vida and ElcalFlex. Approximately 60% of production is dedicated to bioequivalent generic medications, with all products manufactured in GMP-certified facilities. The portfolio is distributed domestically through Cenabast and exported to other regional countries.

Differentiator

Problem solved

Functional benefit

Brands

• D'Vida: Vitamins, minerals and supplements brand
• ElcalFlex

Products and services

• D'Vida Sub-brand of Laboratorios Andrómaco offering vitamins, minerals, and supplements as part of the company's therapeutic product portfolio for Chilean patients.
• ElcalFlex Sub-brand of Laboratorios Andrómaco focused on calcium and flexibility solutions within the vitamins, minerals, and supplements category.
• Bioequivalent Medications Bioequivalent generic medications manufactured in GMP-certified facilities, representing 60% of the company's production output and serving as quality alternatives to brand-name drugs.
• Generic Medications Quality generic pharmaceutical products produced locally in Chile, complementing the bioequivalent portfolio and supporting affordable access through Cenabast and export channels.
• Central Nervous System Medications Pharmaceutical products targeting Central Nervous System conditions, part of Laboratorios Andrómaco's therapeutic portfolio offered to Chilean patients and healthcare providers.

Quantifiable outcome

• 60% of production dedicated to generic medications, increasing patient access to affordable healthcare

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• CenabastcoreChannel Partner/ Reseller/ DistributorLaboratorios Andrómaco is positioned as one of the most important providers through Cenabast, the Chilean government's centralized pharmaceutical procurement system. This partnership enables the company to supply quality medications to public healthcare facilities nationwide.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Laboratorio Bagó: Argentine-founded multinational pharmaceutical group with a strong presence across Latin America, competing in generics, branded generics, and specialty therapeutics, including the Chilean market.
• Genomma Lab Internacional: Mexican pharmaceutical company with a strong OTC and consumer healthcare portfolio across Latin America, overlapping with Andrómaco's D'Vida and ElcalFlex supplement brands.
• Laboratorios Richmond: Argentine pharmaceutical laboratory producing generics, branded generics, and specialty products, with operations across Latin America and overlapping presence in export markets targeted by Andrómaco.
• Laboratorios Chile: One of the most established Chilean pharmaceutical laboratories, directly competing with Laboratorios Andrómaco in the local generics and branded pharmaceutical market, including through Cenabast supply contracts.
• Megalabs: Latin American pharmaceutical company operating in generics and branded generics across multiple LATAM countries, with a similar product portfolio and channel strategy to Andrómaco.
• Eurofarma: Brazilian multinational pharmaceutical company with a broad generics and branded generics portfolio and significant presence in Latin American markets, including Chile.

Regional players

• Farmindustria: Leading Peruvian pharmaceutical manufacturer with a generics and branded generics portfolio serving Andean and broader LATAM markets, comparable in size and positioning to Andrómaco.

Broad incumbents

• Cipla: Indian global generic pharmaceutical manufacturer with expanding presence in Latin American tenders, representing the low-cost import competition that pressures domestic LATAM generic manufacturers like Andrómaco.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with a large portfolio of off-patent molecules, providing indirect competitive pressure on Andrómaco in the Chilean and LATAM generics markets.
• Sandoz (Novartis): One of the world's largest generic pharmaceutical companies, competing with Andrómaco in the global and LATAM generics space with far greater scale, R&D, and supply chain capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Andromaco